Comorbid Conditions of Attention deficit / hyperactive disorders (CoCA) - Implementing and piloting: m-Health approaches for monitoring and coaching chronobiology and physical activity in ADHD and comorbid conditions

Gespeichert in:
Bibliographische Detailangaben
Deutscher übersetzter Titel:Komorbiditäten der Aufmerksamkeits-Defizit/ Hyperaktivitätsstörung – Implementierung und Pilotierung von “m-Health“ (mobile-Health) Ansätzen zur Beobachtung und Förderung des chronobiologischen Rhythmus und körperlicher Aktivität bei ADHS mit komorbiden Krankheitsfaktoren
Leiter des Projekts:Ebner-Priemer, Ulrich Walter (Karlsruher Institut für Technologie / Institut für Sport und Sportwissenschaft / Lehrstuhl für Angewandte Psychologie, Tel.: +49 721 608 42610, ulrich.ebner-priemer at kit.edu)
Mitarbeiter:Koch, Elena Doris (Karlsruher Institut für Technologie / Institut für Sport und Sportwissenschaft / Lehrstuhl für Angewandte Psychologie, Tel.: +49 721 608 47543, elena.koch at kit.edu)
Forschungseinrichtung:Karlsruher Institut für Technologie / Institut für Sport und Sportwissenschaft / Lehrstuhl für Angewandte Psychologie
Finanzierung:Europäische Kommission
Kooperationspartner:Universität Frankfurt am Main ; Universidad de Granada ; King’s College London ; Universitätsmedizin Rostock ; Vall d'Hebron Institut de Recerca; Universiteit Nijmegen / Medisch Centrum
Format: Projekt (SPOFOR)
Sprache:Englisch
Projektlaufzeit:01/2016 - 12/2020
Schlagworte:
Erfassungsnummer:PR020160800154
Quelle:Jahreserhebung

Ziel

The risk for comorbid obesity and major depressive disorder is increased in adolescents and adults with Attention Deficit / Hyperactive Disorders (ADHD) and adolescent ADHD predicts adult obesity and major depressive disorder (Albayrak et al., 2013; Cortese et al., 2013; Lee et al., 2013). Bright light therapy improves day-night rhythm and is an established therapy for major depression in adolescents and adults (Golden et al., 2005). Exercise prevents and reduces obesity in adolescents and adults and also improves depressive symptoms (Blumenthal et al., 2007; Nigg, 2013). Building on the results of the mobile-Health (m-Health) app development, the aim of the current pilot randomized controlled study is to establish effect sizes of two kinds of interventions (bright light therapy and exercise) targeting the prevention of obesity and depressive symptoms.

Planung

The study is a three arm phase pilot randomized, blinded, controlled study with five measurement points (T1: diagnosis, start of 1 week m-Health baseline assessment; T2: randomization prior to start of intervention, baseline interviews and questionnaires; T3: mid-intervention assessment; T4: post intervention assessment; T5: 12 weeks follow-up). The study includes two add-on experimental interventions, a 10 week bright light therapy (BLT) and a 10 week aerobic exercise intervention (AEI) which will be tested against treatment as usual (TAU). N=219 ADHD individuals aged 14-30 years will be randomized to one of the three groups. An m-Health approach to monitor target behaviour will consist of a two sensor system: a mobile phone with integrated sensors and an external, wearable activity sensor (wrist). Additionally to the task of monitoring the interventions, the system will be able to give individualized encouraging feedback to improve physical activity and compliance.

Ergebnisse

The results of the clinical trial will be summarized in reports, which will be distributed to patients and their families, to health care professionals as well as to national and European policy makers.